Logo image of ALAVI.PA

ADVINI (ALAVI.PA) Stock Fundamental Analysis

EPA:ALAVI - Euronext Paris - Matif - FR0000053043 - Common Stock - Currency: EUR

12.5  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALAVI. ALAVI was compared to 24 industry peers in the Beverages industry. ALAVI has a bad profitability rating. Also its financial health evaluation is rather negative. ALAVI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALAVI had negative earnings in the past year.
ALAVI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALAVI reported negative net income in multiple years.
ALAVI had a positive operating cash flow in each of the past 5 years.
ALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

1.2 Ratios

ALAVI has a Return On Assets of -3.19%. This is amonst the worse of the industry: ALAVI underperforms 95.24% of its industry peers.
The Return On Equity of ALAVI (-17.22%) is worse than 95.24% of its industry peers.
Industry RankSector Rank
ROA -3.19%
ROE -17.22%
ROIC N/A
ROA(3y)-0.64%
ROA(5y)-0.43%
ROE(3y)-3.94%
ROE(5y)-2.63%
ROIC(3y)N/A
ROIC(5y)N/A
ALAVI.PA Yearly ROA, ROE, ROICALAVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

Looking at the Gross Margin, with a value of 35.70%, ALAVI is doing worse than 80.95% of the companies in the same industry.
ALAVI's Gross Margin has improved in the last couple of years.
ALAVI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.37%
GM growth 5Y9.57%
ALAVI.PA Yearly Profit, Operating, Gross MarginsALAVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

1

2. Health

2.1 Basic Checks

ALAVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALAVI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALAVI has less shares outstanding
ALAVI has a worse debt/assets ratio than last year.
ALAVI.PA Yearly Shares OutstandingALAVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALAVI.PA Yearly Total Debt VS Total AssetsALAVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that ALAVI is in the distress zone and has some risk of bankruptcy.
ALAVI has a Altman-Z score of 0.81. This is amonst the worse of the industry: ALAVI underperforms 95.24% of its industry peers.
ALAVI has a debt to FCF ratio of 38.51. This is a negative value and a sign of low solvency as ALAVI would need 38.51 years to pay back of all of its debts.
ALAVI's Debt to FCF ratio of 38.51 is on the low side compared to the rest of the industry. ALAVI is outperformed by 71.43% of its industry peers.
ALAVI has a Debt/Equity ratio of 2.65. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ALAVI (2.65) is worse than 95.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 38.51
Altman-Z 0.81
ROIC/WACCN/A
WACC4.76%
ALAVI.PA Yearly LT Debt VS Equity VS FCFALAVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALAVI has a Current Ratio of 0.91. This is a bad value and indicates that ALAVI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.91, ALAVI is doing worse than 61.90% of the companies in the same industry.
A Quick Ratio of 0.30 indicates that ALAVI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.30, ALAVI is doing worse than 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.3
ALAVI.PA Yearly Current Assets VS Current LiabilitesALAVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

ALAVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -423.06%.
Looking at the last year, ALAVI shows a decrease in Revenue. The Revenue has decreased by -4.22% in the last year.
ALAVI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.21% yearly.
EPS 1Y (TTM)-423.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.03%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y4.98%
Revenue growth 5Y2.21%
Sales Q2Q%-1.95%

3.2 Future

Based on estimates for the next years, ALAVI will show a very strong growth in Earnings Per Share. The EPS will grow by 60.38% on average per year.
Based on estimates for the next years, ALAVI will show a small growth in Revenue. The Revenue will grow by 1.96% on average per year.
EPS Next Y14.71%
EPS Next 2Y79.46%
EPS Next 3Y60.38%
EPS Next 5YN/A
Revenue Next Year0.94%
Revenue Next 2Y2.27%
Revenue Next 3Y1.96%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALAVI.PA Yearly Revenue VS EstimatesALAVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALAVI.PA Yearly EPS VS EstimatesALAVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

ALAVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 14.62, which indicates a correct valuation of ALAVI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALAVI is on the same level as its industry peers.
ALAVI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE N/A
Fwd PE 14.62
ALAVI.PA Price Earnings VS Forward Price EarningsALAVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALAVI.
ALAVI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALAVI is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.96
EV/EBITDA 11.04
ALAVI.PA Per share dataALAVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALAVI's earnings are expected to grow with 60.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y79.46%
EPS Next 3Y60.38%

3

5. Dividend

5.1 Amount

ALAVI has a Yearly Dividend Yield of 2.08%.
Compared to an average industry Dividend Yield of 2.86, ALAVI is paying slightly less dividend.
ALAVI's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

On average, the dividend of ALAVI grows each year by 13.49%, which is quite nice.
Dividend Growth(5Y)13.49%
Div Incr Years0
Div Non Decr Years0
ALAVI.PA Yearly Dividends per shareALAVI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.1 0.2 0.3

5.3 Sustainability

ALAVI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
ALAVI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-10.64%
EPS Next 2Y79.46%
EPS Next 3Y60.38%
ALAVI.PA Yearly Income VS Free CF VS DividendALAVI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

ADVINI

EPA:ALAVI (2/4/2025, 7:00:00 PM)

12.5

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)09-20 2024-09-20
Earnings (Next)02-13 2025-02-13/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners23.83%
Ins Owner ChangeN/A
Market Cap49.25M
Analysts82
Price Target19.02 (52.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.35
Dividend Growth(5Y)13.49%
DP-10.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.62
P/S 0.17
P/FCF 8.96
P/OCF 3.99
P/B 0.68
P/tB 1.57
EV/EBITDA 11.04
EPS(TTM)-3.3
EYN/A
EPS(NY)0.85
Fwd EY6.84%
FCF(TTM)1.39
FCFY11.16%
OCF(TTM)3.13
OCFY25.06%
SpS72.1
BVpS18.41
TBVpS7.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.19%
ROE -17.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.7%
FCFM 1.93%
ROA(3y)-0.64%
ROA(5y)-0.43%
ROE(3y)-3.94%
ROE(5y)-2.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.37%
GM growth 5Y9.57%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 38.51
Debt/EBITDA 14.48
Cap/Depr 43%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion 92.95%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.3
Altman-Z 0.81
F-Score6
WACC4.76%
ROIC/WACCN/A
Cap/Depr(3y)73.75%
Cap/Depr(5y)75%
Cap/Sales(3y)3.53%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-423.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.03%
EPS Next Y14.71%
EPS Next 2Y79.46%
EPS Next 3Y60.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y4.98%
Revenue growth 5Y2.21%
Sales Q2Q%-1.95%
Revenue Next Year0.94%
Revenue Next 2Y2.27%
Revenue Next 3Y1.96%
Revenue Next 5YN/A
EBIT growth 1Y-164.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year317.61%
EBIT Next 3Y78.81%
EBIT Next 5YN/A
FCF growth 1Y-44.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.82%
OCF growth 3Y-67.32%
OCF growth 5Y-52.31%